Skip to Content

KU 272 (Oxybutynin chloride extended-release 15 mg)

Pill imprint KU 272 has been identified as Oxybutynin chloride extended-release 15 mg.

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Oxybutynin chloride extended-release 15 mg KU 272
Oxybutynin chloride extended-release 15 mg KU 272 Front
Oxybutynin chloride extended-release 15 mg KU 272 Back
Oxybutynin chloride extended-release 15 mg KU 272
Oxybutynin chloride extended-release
Imprint:
KU 272
Strength:
15 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Kremers Urban
National Drug Code (NDC):
62175-0272
Inactive Ingredients:
lactose anhydrous
lactose monohydrate
mannitol
dextrose, anhydrous
tartaric acid
silicon dioxide
magnesium stearate
cellulose acetate
polyethylene glycol 400
titanium dioxide
ferrosoferric oxide
propylene glycol
hypromellose 2208 (100 mPa.s)
triacetin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0635 AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide